Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Return on Sales (2021 - 2025)

Kezar Life Sciences' Return on Sales history spans 5 years, with the latest figure at 58.93% for Q3 2025.

  • For Q3 2025, Return on Sales fell 6065.0% year-over-year to 58.93%; the TTM value through Sep 2025 reached 58.93%, down 6065.0%, while the annual FY2023 figure was 14.55%, N/A changed from the prior year.
  • Return on Sales for Q3 2025 was 58.93% at Kezar Life Sciences, up from 45.38% in the prior quarter.
  • Across five years, Return on Sales topped out at 119.57% in Q3 2024 and bottomed at 16.31% in Q4 2023.
  • The 5-year median for Return on Sales is 58.25% (2022), against an average of 55.38%.
  • The largest annual shift saw Return on Sales plummeted -9794bps in 2023 before it skyrocketed 12287bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 89.38% in 2021, then dropped by -9bps to 81.63% in 2022, then plummeted by -120bps to 16.31% in 2023, then soared by 419bps to 51.97% in 2024, then grew by 13bps to 58.93% in 2025.
  • Per Business Quant, the three most recent readings for KZR's Return on Sales are 58.93% (Q3 2025), 45.38% (Q2 2025), and 47.71% (Q1 2025).